Legal Representation
Attorney
Jennifer Lee Taylor
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 21, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 20, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 20, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 18, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 18, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 18, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 18, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 23, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 23, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 3, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 12, 2018 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 31, 2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 31, 2018 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 31, 2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 31, 2018 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 31, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 28, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 17, 2018 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jul 14, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 13, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Diagnostic testing kits comprised of medical diagnostic reagents and assays for organ transplant surveillance, including damage, rejection, or tolerance
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical diagnostic services, namely, gene expression testing to determine immune response; medical diagnostic services, namely, cell-free DNA testing for medical purposes; medical diagnostic testing, namely, donor-specific cell-free DNA testing to determine immune response and organ transplant rejection or tolerance; medical diagnostic testing services, namely, blood-based testing to determine immune response and organ transplant rejection or tolerance
First Use Anywhere:
Apr 4, 2018
First Use in Commerce:
Apr 4, 2018
Additional Information
Design Mark
The mark consists of the stylized black wording "HEARTCARE" to the right of a design of two squares. The top square is green and the bottom square is black. The bottom left corner of the green square touches the top right corner of the black square. All instances of the color white represent background and/or transparent areas and are not part of the mark.
Color Claim
The color(s) black and green is/are claimed as a feature of the mark.
Pseudo Mark
HEART CARE
Classification
International Classes
005
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"HEART CARE"